Загрузка...
IL35 hinders endogenous antitumor T-cell immunity and responsiveness to immunotherapy in pancreatic cancer
Although successes in cancer immunotherapy have generated considerable excitement, this form of treatment has been largely ineffective in patients with pancreatic ductal adenocarcinoma (PDA). Mechanisms that contribute to the poor antitumor immune response in PDA are not well understood. Here, we de...
Сохранить в:
| Опубликовано в: : | Cancer Immunol Res |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125203/ https://ncbi.nlm.nih.gov/pubmed/29980536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0710 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|